Business

Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases

Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases

articleShandong Buchang Pharmaceuticals Co., Ltd. Class AMay 8, 20263/news/announcement-on-receipt-by-its-holding-subsidiary-of-the-notice-of-grant-for-the-2026-project-under-the-national-science-and-technology-major-project-for-prevention-and-control-of-emerging-re-emerging-and-major-infectious-diseases
Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases

About this update from Shandong Buchang Pharmaceuticals Co., Ltd. Class A

Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Buchang Pharmaceuticals Co., Ltd. Class A